MARKETS
Top StoryCompany03:30 PM ET

A SpaceX and Tesla Merger Would Build a Conglomerate Just as Spin-Offs Thrive

A Tesla and SpaceX merger would create a top conglomerate as key data suggests that spinoffs are doing better.

Why it
matters

A merger between Tesla and SpaceX would create one giant company. When companies split apart, those smaller pieces often do really well.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

The Wire

Open the wire →
03:15 PM ETEnergy

Brent Crude Oil Price Nears Crucial Level as Trump Prepares Iran Attack

WhyOil prices are going up because of worries about Iran. When people worry about world events, oil often gets more expensive.
Neutral
03:00 PM ETTechnology

Bill Ackman Questions Whether College Is Still Worth It: ‘AI Is Changing Education’

WhyA smart investor is wondering if college is still a good choice. AI and new technology might change how people learn and what jobs need.
Neutral
02:52 PM ETMarkets

AstraZeneca Announced At ESMO Sunday, TAGRISSO Plus Savolitinib Extended Median Overall Survival By Nearly Five Months In Patients With EGFRm Lung Cancer

WhyAstraZeneca's lung cancer medicine helped patients live almost five months longer. This shows the drug works well, which matters when you watch if the company can grow.
Bullish
02:47 PM ETMarkets

AstraZeneca Announced Sunday, Phase 3 CLARITY-Gastric01 Trial Met Primary Overall Survival Endpoint; Sone-Ve Reduced Risk Of Death By 53% In Later-Line CLDN18.2-Positive Advanced Gastric Cancer

WhyAstraZeneca's cancer medicine worked really well in testing. This is good news that shows the company's drug might help sick patients.
Bullish
02:40 PM ETMarkets

Summit Therapeutics Partner Akeso Announced Sunday, Phase 3 HARMONi-GI1 Trial Met Overall Survival Superiority Endpoint For Ivonescimab + Chemotherapy Vs. Durvalumab + Chemotherapy In First-Line Advanced Biliary Tract Cancer

WhySummit's partner Akeso tested a new cancer medicine combination. The new mix worked better than the old one, which is good news for the company.
Bullish

What an alert looks like

Sample
NVDA$145C · Jul 19$4.2M
NVIDIA Corp
LEANS DIRECTIONAL · 72/100single namesweep · 7 exchangesask side 88%3rd day building

The readSomebody paid full ask for NVDA upside. Seven exchanges at once. Same strike, third day in a row. Money in a hurry keeps coming back. That reads like a bet, not an umbrella.

Leans DIRECTIONAL: single name, sweep, ask side, 3rd day building. The number is how hard the tells pushed, never odds. Still a lean, never a certainty. One print is never proof of direction. Notable activity, never a signal. Educational, not financial advice.

What members say

This is how you bounce back from an L. Don't fold, just show up!
MecaCommunity member

Individual member experiences.. results are not typical and not a promise of performance. We educate, not advise.

Who’s behind the desk

Jade · The Stock Babie

Jade · The Stock Babie

Trader · Mentor · Author

Over a decade navigating fast-paced markets, 20,000+ students taught, and one mission: make the market make sense. No jargon, no overthinking. Babie's Radar is the same flow desk Jade reads every morning, decoded so you actually understand it.

10+
Years in the market
20,000+
Students taught
2,000+
Community members
Meet Your Mentor →

Explore the desk

Command center